» Articles » PMID: 36858911

Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit

Overview
Specialty Pulmonary Medicine
Date 2023 Mar 1
PMID 36858911
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The aim of our work has been to describe the results of the clinical audit carried out in 2021 and to compare the results with 2015 EPOCONSUL audit.

Methods: EPOCONSUL 2021 is a cross-sectional audit that evaluated the outpatient care provided to patients with a diagnosis of chronic obstructive pulmonary disease (COPD) in respiratory clinics in Spain with prospective recruitment between April 15, 2021, and January 31, 2022.

Results: A total of 45 hospitals participated in the 2021 audit and 4.225 clinical records of patients were evaluated. Clinical phenotype according to the Spanish National Guidelines for COPD care (GesEPOC) was reported in 63.1% of the audited patients, and the COPD type assessment for the Global initiative for chronic Obstructive Lung Disease (GOLD) was present in 38.3%. There was an improved compliance with clinical practice guideline (CPG) recommendations in the 2021 audit with respect to the 2015 audit. There was an increase in the proportion of cases with alfa-1-antitrypsin serum level testing available (audit 1: 18.9%; audit 2: 38.7%, p<0.001) and 6-min walk test carried out (audit 1: 24%; audit 2: 45.2%, p<0.001). However, these significant variations adherence to CPG recommendations were not reached for the clinical evaluation and therapeutic intervention category when adjusting for patient and resource variables.

Conclusions: The 2021 EPOCONSUL audit showed increased adherence to recommendations although they seem to be related to the availability of resources for care. These results should be taken into account in order to establish improvements in resources to achieve a better quality of care.

Citing Articles

Insights from Real-World Evidence on the Use of Inhalers in Clinical Practice.

Calle Rubio M, Adami Teppa P, Rodriguez Hermosa J, Garcia Carro M, Tallon Martinez J, Riesco Rubio C J Clin Med. 2025; 14(4).

PMID: 40004748 PMC: 11856687. DOI: 10.3390/jcm14041217.


Resources and Readmission for COPD Exacerbation in Pneumology Units in Spain: The COPD Observatory Project.

Calle Rubio M, Cebollero Rivas P, Esteban C, Fuster Gomila A, Garcia Guerra J, Golpe R Healthcare (Basel). 2025; 13(3).

PMID: 39942506 PMC: 11817094. DOI: 10.3390/healthcare13030317.


Clinical control in COPD and therapeutic implications: The EPOCONSUL audit.

Calle Rubio M, Miravitlles M, Cataluna J, Lopez-Campos J, Navarrete B, Ferrer M PLoS One. 2025; 20(1):e0314299.

PMID: 39787174 PMC: 11717229. DOI: 10.1371/journal.pone.0314299.


Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit.

Calle Rubio M, Miravitlles M, Lopez-Campos J, Soler-Cataluna J, Navarrete B, Fuentes-Ferrer M J Clin Med. 2024; 13(4).

PMID: 38398268 PMC: 10889736. DOI: 10.3390/jcm13040955.


[Detection of cases of Alpha-1 Antitrypsin Deficiency, Should We Restrict or Expand?].

Hernandez Perez J, Lopez Charry C Open Respir Arch. 2023; 5(3):100262.

PMID: 37649983 PMC: 10463247. DOI: 10.1016/j.opresp.2023.100262.